Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Dencatistat is an inhibitor of CTP synthase 1 (CTPS1; IC50 = 0.0093 µM), the enzyme that catalyzes the rate-limiting step in the conversion of UTP to CTP.1 It is selective for CTPS1 over CTPS2 (IC50 = 12.62 µM). Dencatistat inhibits the proliferation of nine cell lines derived from T cell-based cancers (IC50s = 2-183 nM) and 12 cell lines derived from B cell-based cancers (IC50s = 3-356 nM). It also inhibits the proliferation of JeKo-1 mantle cell lymphoma and DoHH2 B cell lymphoma cells and induces apoptosis in MOLT-4, Jurkat, and DoHH2 cells. Dencatistat (6-50 mg/kg every other day) reduces tumor growth in a JeKo-1 mouse xenograft model.
WARNING This product is not for human or veterinary use.